Measured low-value imaging
Claims-based LVC pool at Medicare allowed for 100,000 attributed lives — $4.20M[8].
ROI narrative
Here's the money — conservatively. Modeled for 100,000 attributed lives, avoidable low-value imaging lands near $1.05M/yr, of which $525K is retained at a 50% Shared Savings track[8]. Your inputs will differ — run your own numbers.
ARKA helps organisations carrying total cost of care turn low-value imaging into attributable shared savings — a risk-adjusted peer comparison ledger for attributed lives, with no EHR integration for the first product — ~$1M avoidable per 100,000 lives modelled, of which 50–75% is retained under ACO Shared Savings Program tracks.
Modeled, conservative estimate under the Vol III §9 per-attributed-life model. ARKA is Non-Device CDS — figures are decision-support economics, not a guarantee of outcomes. Reduction rate is the trial difference-in-differences, never the raw within-arm drop.
Each step below is a conservative, sourced estimate under the Vol III §9 per-attributed-life model. ARKA is Non-Device CDS — the ordering clinician retains full responsibility for the final decision.
Claims-based LVC pool at Medicare allowed for 100,000 attributed lives — $4.20M[8].
DiD-bounded reduction (6 pp), never the raw within-arm drop — $1.05M/yr[8].
Buyer retention at MSSP BASIC Level E (50%); Enhanced tracks retain up to 75% — $525K retained at the default track.
Modules 1–2 run on a claims extract. If you stop, you stop sending a file — no schema residue, no IT committee for the first product.
CMS-0057-F sets a specific denial reason requirement enforced through 2026 and four FHIR APIs (including Da Vinci PAS) by January 1, 2027. CMS-0057-F compliance matrix. The risk thesis does not depend on this rule.
100,000 attributed lives · measured LVC pool $4.20M · 50% shared-savings retention[8].
Modeled — your inputs will differ. Figures use the Vol III §9 per-attributed-life model; each assumption, its source, and its provenance are documented in the ROI methodology.
Measured LVC pool $4.20M[8] Modeled | Modeled avoided / yr $1.05M[8] Modeled | Retained by buyer $525K[8] Modeled | Year-1 net $297K[8] Modeled |
Avoided spend uses the trial difference-in-differences, never the raw within-arm drop. Retained dollars apply the Shared Savings Program track. Payback uses a ~2.3× first-year return multiple on retained savings. Payback under six months at defaults.
Modeled economics get you to a business case. Measured outcomes get you to a contract. We align on KPIs before go-live — low-value imaging rate against a locked pre-period, retained shared savings by risk track, and appropriateness distribution — using the framework in our Outcomes & KPI guide.
ROI narrative
Here's the money — conservatively. Modeled for 100,000 attributed lives, avoidable low-value imaging lands near $1.05M/yr, of which $525K is retained at a 50% Shared Savings track[8]. Your inputs will differ — run your own numbers.
ARKA helps organisations carrying total cost of care turn low-value imaging into attributable shared savings — a risk-adjusted peer comparison ledger for attributed lives, with no EHR integration for the first product — ~$1M avoidable per 100,000 lives modelled, of which 50–75% is retained under ACO Shared Savings Program tracks.
Modeled, conservative estimate under the Vol III §9 per-attributed-life model. ARKA is Non-Device CDS — figures are decision-support economics, not a guarantee of outcomes. Reduction rate is the trial difference-in-differences, never the raw within-arm drop.
Each step below is a conservative, sourced estimate under the Vol III §9 per-attributed-life model. ARKA is Non-Device CDS — the ordering clinician retains full responsibility for the final decision.
Claims-based LVC pool at Medicare allowed for 100,000 attributed lives — $4.20M[8].
DiD-bounded reduction (6 pp), never the raw within-arm drop — $1.05M/yr[8].
Buyer retention at MSSP BASIC Level E (50%); Enhanced tracks retain up to 75% — $525K retained at the default track.
Modules 1–2 run on a claims extract. If you stop, you stop sending a file — no schema residue, no IT committee for the first product.
CMS-0057-F sets a specific denial reason requirement enforced through 2026 and four FHIR APIs (including Da Vinci PAS) by January 1, 2027. CMS-0057-F compliance matrix. The risk thesis does not depend on this rule.
100,000 attributed lives · measured LVC pool $4.20M · 50% shared-savings retention[8].
Modeled — your inputs will differ. Figures use the Vol III §9 per-attributed-life model; each assumption, its source, and its provenance are documented in the ROI methodology.
Measured LVC pool $4.20M[8] Modeled | Modeled avoided / yr $1.05M[8] Modeled | Retained by buyer $525K[8] Modeled | Year-1 net $297K[8] Modeled |
Avoided spend uses the trial difference-in-differences, never the raw within-arm drop. Retained dollars apply the Shared Savings Program track. Payback uses a ~2.3× first-year return multiple on retained savings. Payback under six months at defaults.
Modeled economics get you to a business case. Measured outcomes get you to a contract. We align on KPIs before go-live — low-value imaging rate against a locked pre-period, retained shared savings by risk track, and appropriateness distribution — using the framework in our Outcomes & KPI guide.